ChemicalBook > CAS DataBase List > GSK2850163

GSK2850163

Product Name
GSK2850163
CAS No.
2121989-91-9
Chemical Name
GSK2850163
Synonyms
GSK2850163;GSK2850163, 10 mM in DMSO;inhibit,IRE1,GSK 2850163,Inhibitor,Inositol requiring enzyme 1,GSK2850163,GSK-2850163;2,7-Diazaspiro[4.5]decane-7-carboxamide, 2-[(3,4-dichlorophenyl)methyl]-N-[(4-methylphenyl)methyl]-, (5R)-
CBNumber
CB23386486
Molecular Formula
C24H29Cl2N3O
Formula Weight
446.41
MOL File
2121989-91-9.mol
More
Less

GSK2850163 Property

Boiling point:
625.6±55.0 °C(Predicted)
Density 
1.28±0.1 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
DMSO : 67.5 mg/mL (151.21 mM);Water : < 0.1 mg/mL (insoluble)
form 
oil
pka
13.81±0.20(Predicted)
color 
colorless to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SML1684
Product name
GSK2850163
Purity
≥98% (HPLC)
Packaging
5MG
Price
$105
Updated
2023/06/20
Sigma-Aldrich
Product number
SML1684
Product name
GSK2850163
Purity
≥98% (HPLC)
Packaging
25MG
Price
$424
Updated
2023/06/20
ChemScene
Product number
CS-0039356
Product name
GSK2850163
Purity
98.50%
Packaging
5mg
Price
$80
Updated
2021/12/16
ChemScene
Product number
CS-0039356
Product name
GSK2850163
Purity
98.50%
Packaging
10mg
Price
$140
Updated
2021/12/16
ChemScene
Product number
CS-0039356
Product name
GSK2850163
Purity
98.50%
Packaging
25mg
Price
$290
Updated
2021/12/16
More
Less

GSK2850163 Chemical Properties,Usage,Production

Biochem/physiol Actions

GSK2850163 is a highly selective inhibitor of inositol requiring enzyme-1 alpha (IRE1α) with dual activity: it inhibits IRE1α kinase activity with an IC50 value of 20 nM and RNase activity with an IC50 value of 200 nM. IRE1α is a dual serine/threonine-protein kinase/endoribonuclease with two enzymatic domains: a trans-autophosphorylation domain and and endoribonuclease (RNase) domain. When activated, usually in response to endoplasmic reticulum (ER) stress such as the unfolded protein response (UPR), IRE1α oligomerizes and activates mRNA splicing of adaptive XBP1 transcription factor, which upregulates ER chaperones and ER associated degradation (ERAD) genes that promote degradation of ER unfolded proteins and facilitate recovery from ER stress. However, if ER stress is too high or chronic, IRE1α is hyperactivated, increasing many ER mRNAs, resulting in apoptosis. GSK2850163 interacts with IRE1α catalytic residues Lys599 and Glu612, displacing the kinase activation loop to the inactive DFG-out conformation. The rearrangement of the kinase domain-dimer interface also results in the RNAse domains rotating away from each other, inhibiting the RNase activity.

GSK2850163 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

GSK2850163 Suppliers

TargetMol Chemicals Inc.
Tel
+1-781-999-5354 +1-00000000000
Email
marketing@targetmol.com
Country
United States
ProdList
32161
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
TargetMol Chemicals Inc.
Tel
Email
support@targetmol.com
Country
United States
ProdList
38631
Advantage
58
Aladdin Scientific
Tel
+1-+1(833)-552-7181
Email
sales@aladdinsci.com
Country
United States
ProdList
52924
Advantage
58

2121989-91-9, GSK2850163Related Search:


  • GSK2850163
  • 2,7-Diazaspiro[4.5]decane-7-carboxamide, 2-[(3,4-dichlorophenyl)methyl]-N-[(4-methylphenyl)methyl]-, (5R)-
  • inhibit,IRE1,GSK 2850163,Inhibitor,Inositol requiring enzyme 1,GSK2850163,GSK-2850163
  • GSK2850163, 10 mM in DMSO
  • 2121989-91-9